Category Archives: Clinical Accelerator
Clinical Accelerator announces collaboration with CryoTherapuetics – a medical device company focused on treating coronary artery disease
Clinical Accelerator, a full-service, medical device focused contract research organization, is pleased to announce a new partnership with CryoTherapeutics – an early-stage European medical device company which has developed a novel cryoenergy therapy for the treatment of inflamed atherosclerotic plaque, … Continue reading
Posted in Clinical Accelerator, Medical Devices
Leave a comment
Clinical Accelerator announces collaboration with CryoTherapuetics – a medical device company focused on treating coronary artery disease
Clinical Accelerator, a full-service, medical device focused contract research organization, is pleased to announce a new partnership with CryoTherapeutics – an early-stage European medical device company which has developed a novel cryoenergy therapy for the treatment of inflamed atherosclerotic plaque, … Continue reading
Posted in Cardiology, Clinical Accelerator, Medical Devices
Leave a comment
Clinical Accelerator announces collaboration with Deerfield Catalyst, a medtech incubator committed to developing transformational solutions to improve patient outcomes and streamline care
Clinical Accelerator, a full-service, medical device focused contract research organization, is pleased to announce a collaboration with Deerfield Catalyst. The company combines the resources of two established health pioneers: Coridea, a New-York based, premier Medical Device Incubator; and Deerfield, an … Continue reading
Posted in Clinical Accelerator, Medical Devices
Leave a comment
AtriAN Medical’s Clinical Data Highlighted at the 2022 AF Symposium
Pioneering cardiac autonomic pulsed field ablation (PFA) technology provides a unique option for enhancing the durability of AF ablation. GALWAY, Ireland, Jan. 17, 2022 /PRNewswire/ — Irish medical device company AtriAN Medical today announced that clinical data from it’s first-in-human study was presented … Continue reading
Clinical Accelerator announces collaboration with InterVene for developing an endovascular device for deep vein valve failure
Clinical Accelerator is pleased to announce that is has begun a collaboration with InterVene, to run an early human feasibility study (EHFS) on their novel endovascular device – BlueLeaf Endovenous Valve Formation System – for deep vein valve failure. Currently, … Continue reading
Posted in Cardiology, Clinical Accelerator, Medical Devices
Leave a comment
Clinical Accelerator collaborates with Metavention on a study of a novel medical device for hypertension
Clinical Accelerator and Metavention have recently entered into a collaboration allowing Clinical Accelerator to join the program of feasibility studies already under way in the United States, New Zealand and Australia. Our organization will participate in the renal denervation trial … Continue reading
Clinical Accelerator receives ISO 9001:2015 quality certification
Clinical Accelerator has reached a new milestone by being awarded the ISO 9001:2015 certification. The 2015 edition of ISO 9001, created by the International Organization Standardization (ISO), provides the latest standards that must be followed in order to demonstrate the … Continue reading
Posted in Clinical Accelerator
Leave a comment
Replicor publishes its REP 301-LTF study achieving durable functional cure of HDV and HBV, inactivation of cccDNA and elimination of integrated HBV DNA
Below, we are re-publishing with permission the press-release issued by Replicor Inc. on November 16, 2020 MONTREAL, November 16th, 2020 – Replicor Inc., a privately held biopharmaceutical company targeting functional cure for patients with chronic hepatitis B and D infection, … Continue reading
Clinical Accelerator announces collaboration with Noxopharm to advance idronoxil (NOX66), a novel treatment for COVID-19
Clinical Accelerator is pleased to announce a new collaboration with Noxopharm, a leading Australian drug development company. Noxopharm’s NOX66 therapy has received trial approval and is now in a Phase Ib, open-label trial by Clinical Accelerator in Eastern Europe. The … Continue reading
Axon Therapies Announces Positive Results From First-In-Human Clinical Study in Late-Breaking Clinical Trial Session At 2020 Virtual HFSA Conference
Below, we are re-publishing with permission the press-release issued by Axon Therapies, Inc. on October 09, 2020 Satera™ Ablation System demonstrates success as a frontline treatment of heart failure NEW YORK, Oct. 9, 2020 /PRNewswire/ — Axon Therapies, a Coridea portfolio company focused … Continue reading
clinicalaccelerator.com 
You must be logged in to post a comment.